问题 › 我们总是靠折扣拿下交易 › 律所
常规折扣通常是证明问题和激励问题，几乎从来不是费率问题。 律所的难点在于结构：28名股权合伙人中有19人已满55岁，过去八年既无正式横向招聘计划，也无从律师到合伙人的晋升通道。因此任何可信方案都必须同时兼顾82%的实现率和68%的利用率，而这正是多数内部分析止步之处，因为两者分属不同系统。
常规折扣通常是证明问题和激励问题，几乎从来不是费率问题。 律所的难点在于结构：28名股权合伙人中有19人已满55岁，过去八年既无正式横向招聘计划，也无从律师到合伙人的晋升通道。因此任何可信方案都必须同时兼顾82%的实现率和68%的利用率，而这正是多数内部分析止步之处，因为两者分属不同系统。
当折扣成为常态，有效费率已重置为实现水平，公布费率只是装饰。这带来的成本不止于利润：它向客户传递了律所实际收取的金额，而在股权合伙人仍控制各自案件计费的情况下，很难逆转。
原因一致。交付价值未向客户证明，费用便成为唯一可谈变量。或者合伙人激励以计费时长和案件胜出为准，这时折扣正是理性行为。或者计费裁量权不受限制，而不受限制的裁量权总会在五个业务组中被用尽。
诊断在于分布。如果实现率在财年末或特定股权合伙人处集中，原因就是激励与权限，而非费率。目前82%的实现率、68%的利用率和112天的回款周期已包含这些模式。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 实现率在财年最后一个季度或月份大幅下降。
✓ 股权合伙人之间，同类同规模案件的实现率差异显著。
✓ 股权合伙人要求降低费率或更多核销权限，而不是收紧范围或强化结果证明。
通常会让情况更糟的做法。 把公布小时费率下调至当前实现水平，这会重置锚点，并在两个账单周期内再次出现同样缺口。
It is for you if you run or finance a law firm and discounts spike at period end. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家律所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Ashgrove Legal LLP, a sample company profile used for testing rather than a customer — £24.8 m gross revenue from five practice groups.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Scale the only practice hitting 88 % realisation to fund its own growth and close the succession gap.
| Investment required | £240 k (remaining FY2026 discretionary cap after £180 k IT commitment) |
| Expected return | 1.4–1.6× cash-on-cash within 24 months at current realisation rates. |
| Revenue, year 1 | £25.4–25.7 m firm-wide (+£0.6–0.9 m incremental) |
| Revenue, year 2 | £26.5–27.1 m firm-wide (+£1.1–1.3 m incremental from B&F segment) |
| Revenue, year 3 | £27.8–28.6 m firm-wide (+£1.3–1.5 m incremental) |
| Exit criteria | Strategy must be reversed if, within 18 months, segment revenue has not reached £2.4 m annualised OR cumulative net profit contribution is below £150 k, OR if any lateral hire’s personal billings fall below 1 200 hours in any rolling 6-month period. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 定价与收入优化, one of 29 engagements the platform runs. For 律所 it works through 82 % realisation, 68 % utilisation, £184 k profit per equity partner and 112 lock-up days, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
限制裁量权，按利润而非收入支付报酬。折扣是对收入指标加无限定价权的理性回应。
不是——如果是有意用作交换期限、规模或推荐的结构化安排，就不是问题。作为谈判结束时的条件反射，它只是无谓让出利润。
续约时提前通知并说明理由，接受部分流失。否则就是永久的两套价格，最终会被市场其余部分发现。
Materially, yes. 19 of 28 equity partners aged 55 or over with no formal lateral hire programme or associate-to-partner track for eight years — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82 % realisation, 68 % utilisation, £184 k profit per equity partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82 % realisation and 68 % utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית